Clinex1%

Clinex is a topical (intravaginal) antibiotic of the lincosamide class. Its established, FDA-approved indication is:

• Bacterial vaginosis (BV): Treatment of bacterial vaginosis in non-pregnant women, caused by susceptible strains of Gardnerella vaginalis and other BV-associated anaerobic bacteria. This is the primary and best-supported use of Clinex.

Guideline-supported use in specific situations: Some clinical guidelines support use of Clinex for symptomatic bacterial vaginosis in pregnant women when prescribed by a physician, although oral therapy is generally preferred, especially later in pregnancy (see Pregnancy and Lactation).

Clinex is not indicated for vaginal infections caused by Candida (yeast), Trichomonas vaginalis, Chlamydia, Neisseria gonorrhoeae, Herpes simplex, or Treponema pallidum (syphilis); these require different treatments. There is no well-established general off-label use beyond bacterial vaginosis for this formulation.

Each applicatorful of Clindamycin [Vaginal cream/Lotion] typically contains clindamycin phosphate equivalent to approximately 100 mg of clindamycin (as a 2% w/w vaginal cream/lotion), in a base vehicle that may contain mineral oil and other excipients. Strength and exact excipients can vary slightly by manufacturer/brand; always check the product label of the specific pack dispensed.

Clinex contains clindamycin, a semi-synthetic antibiotic of the lincosamide class, formulated as a cream or lotion for local (intravaginal) application. It works by stopping the growth of bacteria responsible for bacterial vaginosis, restoring a healthier vaginal bacterial balance.

Unlike oral or injectable clindamycin, this vaginal formulation acts predominantly at the site of application, with only partial systemic absorption. It is applied using a supplied applicator, usually once daily at bedtime, for a physician-directed course (commonly 3 or 7 consecutive nights depending on the specific product).

Clinex belongs to the lincosamide class of antibiotics, formulated specifically as a topical/intravaginal antimicrobial agent for gynecological use.

Clindamycin [Vaginal cream/Lotion] contains clindamycin phosphate, an inactive prodrug ester that is hydrolyzed to active clindamycin base after vaginal application. Clindamycin binds to the 50S ribosomal subunit of susceptible bacteria, inhibiting bacterial protein synthesis. This action is primarily bacteriostatic, though it can be bactericidal at higher local concentrations against certain susceptible organisms.

Clindamycin [Vaginal cream/Lotion] is active against many of the anaerobic and facultative bacteria associated with bacterial vaginosis, including Gardnerella vaginalis, Mobiluncus species, Bacteroides species, and Peptostreptococcus species. It has no clinically useful activity against normal lactobacilli, fungi, or most sexually transmitted pathogens.

Following intravaginal application, a variable but clinically relevant fraction of the dose is absorbed systemically (studies show it can approach levels seen with lower oral doses), which is why systemic precautions (e.g., colitis risk) still apply, though at lower likelihood than with oral or intravenous clindamycin.

For intravaginal use only. Clinex is not for oral, ophthalmic, or injectable use. Use the applicator supplied with the pack; do not substitute another device. Apply at approximately the same time each night for the full course prescribed. Avoid intercourse or use alternative non-latex protection during treatment (see Interaction and Precautions).

Barrier contraceptive interaction (clinically important): The oil-based vehicle in Clinex may weaken latex or rubber products, including latex condoms, cervical caps, and vaginal contraceptive diaphragms, reducing their effectiveness for contraception and for protection against sexually transmitted infections. Patients should be advised to avoid relying on these latex barrier methods during treatment and for several days after completing treatment (follow the specific product label, typically 3–5 days); an alternative, non-latex method of contraception/protection should be used during this period.

Systemic drug interactions: Because vaginal application results in only partial systemic absorption, clinically significant systemic drug interactions are uncommon with Clinex compared with oral or injectable clindamycin. However, as a precaution:

• Neuromuscular blocking agents: Clindamycin has intrinsic neuromuscular blocking properties and may theoretically potentiate the action of neuromuscular blocking agents if significant systemic absorption occurs; use with caution if surgery is anticipated.
• Other vaginal products: Concurrent use of other intravaginal products (e.g., spermicides, other vaginal medications) during treatment with Clinex is not well studied and should be avoided unless directed by a physician.

Inform your physician or pharmacist about all other medicines, supplements, or vaginal products you are using before starting Clinex.

Most side effects of Clinex are local and mild, but some systemic effects can occur due to partial vaginal absorption.

Common side effects

• Vulvovaginal candidiasis (secondary yeast infection) — a recognized consequence of disrupting normal protective vaginal bacterial flora during antibiotic treatment; may present as itching, thick discharge, or irritation during or after the course.
• Local vaginal or vulvar itching, burning, or irritation.
• Increased or abnormal vaginal discharge.
• Headache, and mild abdominal or pelvic discomfort.

Less common / serious side effects

• Antibiotic-associated colitis (including pseudomembranous colitis): Rare with vaginal use, but can occur due to systemic absorption; report persistent watery or bloody diarrhea, severe abdominal cramping, or fever promptly.
• Allergic/hypersensitivity reactions such as rash or localized swelling.

Contact a physician if side effects are severe, persistent, or concerning.

Pregnancy: Clinex should be used during pregnancy only if clearly needed and specifically directed by a physician, as potential benefit must be weighed against potential risk. Some guidelines support its use for bacterial vaginosis in pregnancy under physician supervision, but many experts prefer oral therapy, particularly during the second half of pregnancy, due to data suggesting a possible association between vaginal clindamycin use later in pregnancy and adverse neonatal outcomes in some studies. Do not use during pregnancy without consulting a physician first.

Lactation: Systemic absorption from vaginal application is limited compared with oral/injectable clindamycin, but some drug may pass into breast milk. Use during breastfeeding only if considered necessary by a physician; monitor the breastfed infant for any gastrointestinal disturbance such as diarrhea or rash, and consult a doctor if these occur.

Complete the full course: Take Clinex exactly as prescribed by your physician; do not stop, extend, skip doses, or share this medicine with others without medical advice. Stopping early, even if symptoms resolve, increases the risk of recurrence and antibiotic resistance.

Barrier contraception: The product base may weaken latex condoms and diaphragms; use alternative, non-latex contraception/protection during treatment and for several days afterward (see Interaction).

Avoid intercourse during treatment where possible, or follow specific product guidance, to allow adequate contact time and reduce irritation.

Colitis risk: Discontinue and seek medical advice if severe, persistent, or bloody diarrhea develops during or after treatment, as this could indicate antibiotic-associated colitis (see Contraindications).

Superinfection: Use may result in overgrowth of non-susceptible organisms, including Candida (vaginal yeast infection); seek medical advice if new or worsening symptoms of itching, discharge, or irritation develop.

Avoid vaginal douching and use of tampons during treatment unless advised by your physician, as these may reduce effectiveness. Do not use if the product seal is broken or the product appears discolored.

Vaginal overdose of Clinex is unlikely to cause serious effects because absorption is limited, but excessive or inappropriate use (e.g., oral ingestion of the vaginal product) could increase the risk of systemic side effects, including gastrointestinal upset or, rarely, antibiotic-associated colitis. If accidental ingestion occurs, or if a significantly larger-than-prescribed amount is applied and the patient experiences severe diarrhea, abdominal pain, rash, or other concerning symptoms, seek immediate medical attention or contact a poison control center/emergency services. Do not attempt specific home treatment for suspected overdose.

Store at room temperature (below 30°C), away from light and moisture. Keep out of reach of children. Do not freeze. Keep the applicator and tube tightly closed when not in use.

Pregnant women: Use Clinex only if clearly needed and directed by a physician; see Pregnancy and Lactation for details.

Breastfeeding women: Use only if considered necessary by a physician; monitor the infant for gastrointestinal symptoms.

Renal or hepatic impairment: No specific dose adjustment is established for the vaginal formulation due to its limited systemic absorption; however, patients with significant hepatic impairment should use with caution and under medical supervision given clindamycin's hepatic metabolism.

Elderly: No specific dose adjustment is required; used as in other adult women when clinically indicated.

Pediatric patients: See Pediatric Uses.

The typical course of Clinex is 3 or 7 consecutive nights, depending on the specific product and physician's instructions. The full course must be completed even if symptoms resolve earlier, to reduce the risk of recurrence and resistance. Do not use for longer than prescribed without medical advice.

Lincosamide antibiotic; topical/intravaginal antimicrobial agent.

Clindamycin [Vaginal cream/Lotion] delivers clindamycin, which binds the 50S ribosomal subunit of susceptible bacteria and inhibits bacterial protein synthesis, producing a primarily bacteriostatic effect against the anaerobic and facultative bacteria implicated in bacterial vaginosis, thereby helping restore normal vaginal flora balance.

Clinex is not indicated for use in pediatric or prepubertal patients. Bacterial vaginosis treated with this product is a condition of sexually active or reproductively mature women, and safety and efficacy of this vaginal formulation have not been established in children or adolescents who have not reached reproductive maturity. Use in adolescents should only occur under direct physician guidance after appropriate gynecological evaluation.